↓ Skip to main content

High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, October 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#23 of 1,936)
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
1 news outlet
twitter
32 tweeters
reddit
1 Redditor

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer
Published in
Journal of Experimental & Clinical Cancer Research, October 2021
DOI 10.1186/s13046-021-02134-y
Pubmed ID
Authors

Franziska Böttger, Andrea Vallés-Martí, Loraine Cahn, Connie R. Jimenez

Twitter Demographics

The data shown below were collected from the profiles of 32 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 44 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 11%
Researcher 4 9%
Student > Bachelor 3 7%
Student > Doctoral Student 3 7%
Unspecified 3 7%
Other 7 16%
Unknown 19 43%
Readers by discipline Count As %
Medicine and Dentistry 10 23%
Biochemistry, Genetics and Molecular Biology 8 18%
Unspecified 2 5%
Arts and Humanities 1 2%
Social Sciences 1 2%
Other 3 7%
Unknown 19 43%

Attention Score in Context

This research output has an Altmetric Attention Score of 34. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 August 2022.
All research outputs
#945,000
of 21,788,432 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#23
of 1,936 outputs
Outputs of similar age
#28,271
of 424,226 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#4
of 342 outputs
Altmetric has tracked 21,788,432 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,936 research outputs from this source. They receive a mean Attention Score of 3.7. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 424,226 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 342 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.